Tectonic Therapeutic Files for IPO

Ticker: TECX · Form: S-1 · Filed: Mar 26, 2025 · CIK: 1681087

Tectonic Therapeutic, Inc. S-1 Filing Summary
FieldDetail
CompanyTectonic Therapeutic, Inc. (TECX)
Form TypeS-1
Filed DateMar 26, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: ipo, biotech, registration-statement

TL;DR

Tectonic Therapeutic (fka AVROBIO) is going public via S-1 filing.

AI Summary

Tectonic Therapeutic, Inc. filed an S-1 form on March 26, 2025, indicating its intention to go public. The company, formerly known as AVROBIO, Inc. until January 31, 2018, is based in Watertown, MA. This filing suggests Tectonic Therapeutic is seeking capital through an initial public offering to fund its operations and growth in the biological products sector.

Why It Matters

This S-1 filing signals Tectonic Therapeutic's move towards becoming a publicly traded company, which could provide it with significant capital for research and development in the biotechnology space.

Risk Assessment

Risk Level: medium — As a pre-IPO company in the biotech sector, Tectonic Therapeutic faces inherent risks related to clinical trials, regulatory approvals, and market adoption.

Key Numbers

  • 2024-12-31 — Fiscal Year End (Indicates the end of the company's financial reporting year.)
  • 2023-12-31 — Previous Fiscal Year End (Provides a comparative financial period.)
  • 20250326 — Filing Date (The date Tectonic Therapeutic, Inc. submitted its S-1 filing.)

Key Players & Entities

  • Tectonic Therapeutic, Inc. (company) — Filer of the S-1 registration statement.
  • AVROBIO, Inc. (company) — Former name of Tectonic Therapeutic, Inc.
  • 20250326 (date) — Date of the S-1 filing.
  • Watertown, MA (location) — Business and mailing address of Tectonic Therapeutic, Inc.
  • 2836 (industry_code) — Standard Industrial Classification code for Biological Products.

FAQ

What is the primary purpose of this S-1 filing for Tectonic Therapeutic, Inc.?

The S-1 filing is a registration statement filed with the SEC to initiate the process of offering securities to the public, typically for an Initial Public Offering (IPO).

When was Tectonic Therapeutic, Inc. previously known by another name?

Tectonic Therapeutic, Inc. was formerly known as AVROBIO, Inc. until January 31, 2018.

Where is Tectonic Therapeutic, Inc. located?

The company's business and mailing address is 490 Arsenal Way, Suite 210, Watertown, MA 02472.

What is the Standard Industrial Classification (SIC) code for Tectonic Therapeutic, Inc.?

The SIC code listed for Tectonic Therapeutic, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

What is the filing date of this S-1 document?

The S-1 filing was made on March 26, 2025.

Filing Details

This Form S-1 (Form S-1) was filed with the SEC on March 26, 2025 regarding Tectonic Therapeutic, Inc. (TECX).

View full filing on EDGAR

View Full Filing

View this S-1 filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.